Elemind

Country:
USA
Founding year:
2019

Elemind develops a consumer neurotechnology headband for sleep improvement. The company is positioned around wearable “read-write” neurotechnology, with its first commercial product focused on sleep onset, nighttime awakenings, and personalized sleep support. The product sits in the consumer sleep segment, using EEG as the sensing layer for active audio-based intervention.

The system measures brain signals through a headband and delivers acoustic stimulation tailored to the user’s brain rhythms. Its app provides sleep analytics, including sleep duration, sleep efficiency, sleep onset, sleep stages, and movement, while its adaptive software adjusts stimulation based on brain activity and user feedback. The core product logic combines sleep tracking, closed-loop stimulation, and behavioral guidance in a single consumer device.

Elemind targets consumers seeking non-pharmaceutical support for sleep quality and recovery. The company is part of a broader shift from passive sleep tracking toward wearables that sense physiological state and intervene during the night. It is best understood as a consumer sleep neurotechnology company using EEG-guided acoustic stimulation as its primary intervention layer.

Consumer Neurotech
Monitoring
Wellness

Neurofounders Insights

Modality:
EEG
Form Factor:
Headset/cap
Interface Depth:
Non-invasive
Indication:
Sleep
Target user:
Consumers
Regulatory stage:
Non-medical

Seed

Elemind sits in the consumer sleep neurotechnology segment, where EEG is used as an input for active sleep intervention. Its positioning is differentiated by closed-loop acoustic stimulation, placing it between consumer sleep wearables and more technically involved neurofeedback systems.

Related companies

Articles featuring

Elemind

No articles yet!

Press releases

No press releases published yet.